Table 4.
No. of E. coli per Ward | % of Resistance to the Tested Antibiotic | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
CIP | CHL | NAL | GEN | AMP | TET | DOX | SXT | CTX | MEM | |
Ukonga (42) | 23.8 | 21.4 | 33.3 | 19.0 | 27.8 | 50.0 | 27.8 | 33.3 | 42.9 | 5.6 |
Kipawa (18) | 11.1 | 5.6 | 33.3 | 11.1 | 54.8 | 64.3 | 54.2 | 61.9 | 55.6 | 7.1 |
Kinyerezi (35) | 34.3 | 25.7 | 37.1 | 25.7 | 54.3 | 51.4 | 37.1 | 62.9 | 20.0 | 0.0 |
Segerea (58) | 24.1 | 22.4 | 43.1 | 22.4 | 48.3 | 53.4 | 41.4 | 41.4 | 27.6 | 1.7 |
Kisarawe (51) | 60.8 | 62.7 | 64.7 | 47.1 | 76.5 | 80.4 | 60.8 | 80.4 | 47.1 | 11.8 |
Pugu station (18) | 38.9 | 38.9 | 44.4 | 44.4 | 72.2 | 66.7 | 50.0 | 50.0 | 38.9 | 0.0 |
Overall resistance | 34.2 | 32.0 | 44.6 | 28.8 | 57.2 | 62.2 | 46.8 | 57.7 | 36.7 | 5.0 |
p-value | 0.000 | 0.000 | 0.031 | 0.006 | 0.003 | 0.033 | 0.101 | 0.000 | 0.034 | 0.022 |
Key: CIP, ciprofloxacin; CHL, chloramphenicol; NAL, nalidixic acid; GEN, gentamycin; AMP, ampicillin; TET, tetracycline; DOX, doxycycline; SXT, trimethoprim/sulfamethoxazole; CTX, cefotaxime; MEM, meropenem.